|
 
 |
| LETTER TO EDITOR |
|
| Year : 2023 | Volume
: 14
| Issue : 1 | Page : 104 |
|
Necessary to identify latent toxicants associated with COVID-19
Mousa Bamir1, Salman Daneshi2, Salman Farahbakhsh3
1 Department of Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2 Department of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran
3 Department of Health Professional, School of Health, Sirjan University of Medical Sciences, Sirjan, Iran
| Date of Submission | 12-Mar-2022 |
| Date of Acceptance | 07-Apr-2022 |
| Date of Web Publication | 28-Aug-2023 |
Correspondence Address:
Mousa Bamir
Department of Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpvm.ijpvm_82_22
How to cite this article:
Bamir M, Daneshi S, Farahbakhsh S. Necessary to identify latent toxicants associated with COVID-19. Int J Prev Med 2023;14:104 |
Dear Editor
SARS-CoV-2 is a new coronavirus that emerged in 2019 and caused the COVID-19 epidemic, but despite much effort, there is still no specific care standard. The lack of accurate information posed several challenges for health systems, which were accompanied by a wide range of possibly unfamiliar materials for the treatment and prevention of COVID-19.[1] When a major medical crisis such as COVID-19 occurs, and there is no known cure for it, several phenomena may occur, and people to show different behavioral reactions to deal with this condition and treat it with limited knowledge.[2],[3]
However, people are increasingly exposed to social media and the internet, which may lead to self-medication using non-standard methods, which are a prerequisite for diseases such as hypertension, kidney disease, stroke, obesity, diabetes, and liver disease more vulnerable than COVID-19.[4] We performed this study on the cause and effect of these aggravating factors of coronavirus. Emerging evidence shows that many of the unsanitary and non-standard cases used to treat COVID-19 are worse than the disease itself.
It seems that monitoring, prevention, and management of incorrect treatment styles and identification of toxic agents that victims of coronavirus are very important. Here are some of them: High sodium intake in many unhealthy diets, increased access to and use of disinfectants including alcohol, social media advertising about not wearing a mask, vaccine injections and other interventions to create stress and lack of public participation in prevention, induction of incorrect information for self-medication, increase illegal drug use with the false belief that drugs are effective in the treatment and prevention of COVID-19, use of over-the-counter and unsanitary drugs Includes chloroquine and hydroxychloroquine, which have major and completely irresponsible deficiencies for treatment, use of beverages such as sodium hypochlorite, cocaine infusion and fake alcohol with methanol, use of many non-standard herbal medicines, presence in industrial centers and places with high pollution is one of the most common latent toxic agents of COVID-19. Our solution here is to pay attention to medical toxicology and toxicology education by setting up control centers and public information for the public.
Author's contribution
All authors contributed to the conception or design of the work. MB, SD, and SF contributed to the acquisition, analysis, or interpretation of data for the work. MB and SD contributed to drafting the work or revising it critically for important intellectual content. MB contributed to final approval of the version to be published.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM. COVID-19: Therapeutics and their toxicities. J Med Toxicol 2020;16:284-94.  |
| 2. | Kara E, Inkaya AC, Demirkan K. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients? Int J Antimicrob Agents 2020;55:106003. |
| 3. | Neumann NR, Chai PR, Wood DM, Greller HA, Mycyk MB. Medical toxicology and COVID-19: Our role in a pandemic. J Med Toxicol 2020;16:245-7. |
| 4. | Aminpour M, Delgado WE, Wacker S, Noskov S, Houghton M, Tyrrell DL, et al. Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19. BMC Pharmacol Toxicol 2021;22:61. |
|
Search Pubmed for